FLT3 and acute myeloid leukemia: Approximately 25% of all AML carry an internal tandem duplication (ITD) in the juxtamembrane domain of the receptor tyrosine kinase (RTK) FLT3, leading to constitutive PI3K/AKT, ERK and STAT5 signaling [1–3].